Skip to content

Study about effects of macronutrient distribution to glucose control and treatment satisfaction in type 2 diabetes

Study about effects of macronutrient distribution to glucose control and treatment satisfaction in type 2 diabetes - Effects of macronutrient distribution to glucose control and DTSQ

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022132
Enrollment
180
Registered
2016-04-29
Start date
2016-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

We instruct the total daily macronutrient intake and distribution. In only this group, macronutrient distribution: carbohydrate 60 %, protein 17 %, fat 23 %. In all groups, daily total intake of

Sponsors

TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diabetic out-patients whose HbA1c is greater than 5.8 % (NGSP) 15 years-old<= , 80 years-old>

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetic patients 2. Patients whose urinary albumin creatinine ratio (U-ACR) has been greater than 300 mg/gCr 3. Patients has renal dysfunction (eGFR is less than 30 mL/min/1.73m2) 4. Pregnant women 5. Patients estimated by the doctor to be ineligible

Design outcomes

Primary

MeasureTime frame
HbA1c (NGSP), body weight, study interruption ratio, compliance of diet therapy, the total score of the DTSQ first factor (Question no.1,4,5,6,7,8), the score of question no.2 and 3, frequency of reducing, adding, or increasing of antidiabetic drugs.

Secondary

MeasureTime frame
Blood pressure, eGFR, urine albumin creatinine ratio (UACR), serum LDL-C, HDL-C, triglyceride, estimated visceral fat area, development of diabetic retinopathy, death from cardiovascular causes, the rate of myocardial infarction, the rate of stroke, rate of cancer, death from any causes.

Countries

Japan

Contacts

Public ContactTakahiro Tosaki

TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology Diabetes and Endocrinology

nrd49075@nifty.com052-800-2333

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026